Skip to main content

Table 1 (abstract P59). Patient Characteristics

From: Proceedings of the 2018 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Scientific Meeting

  PICU PSV Cohort (n=18)
Median age, years (IQR) 9.5 (5.9-13.7)
Male/Female, n (%) 7 (38.9)/11 (61.1)
Diagnosis, n (%)  
 Refractory Kawasaki disease 6 (33.3)
 Takayasu’s arteritis 5 (27.8)
 ANCA-associated vasculitis 4 (22.2)
 Henoch-Schonlein purpura 2 (11.1)
 Primary CNS Vasculitis 1 (5.6)
 Others 0 (0)
Diagnosis during hospital admission, n (%) 15 (83.3)
Treatment during hospitalization  
 Glucocorticoids 15 (83.3)
 IVIg 7 (38.9)
 Aspirin 5 (27.8)
 Cyclophosphamide 4 (22.2)
 Disease modifying anti-rheumatic drugs 2 (11.2)
 Biologics 1 (5.6)
Median hospital length of stay, days (IQR) 8.5 (4.0-18.8)